Venetoclax and Obinutuzumab Followed by Epcoritamab for the Treatment of Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma, LonGEVity Trial
Conditions
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
Interventions
- PROCEDURE: Biospecimen Collection
- PROCEDURE: Bone Marrow Aspiration
- PROCEDURE: Bone Marrow Biopsy
- PROCEDURE: Computed Tomography
- OTHER: Electronic Health Record Review
- BIOLOGICAL: Epcoritamab
- PROCEDURE: Magnetic Resonance Imaging
- BIOLOGICAL: Obinutuzumab
- DRUG: Venetoclax
Sponsor
City of Hope Medical Center
Collaborators